A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
Public ClinicalTrials.gov record NCT00743769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Phase 1 Study of the Safety and Tolerability of the Intravenous Administration of Thymosin Beta 4 and Its Pharmacokinetics After Single and Multiple Doses in Healthy Volunteers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether the intravenous administration of single- and multiple-ascending doses of Thymosin Beta 4 is safe and tolerable in healthy volunteers.
Study identification
- NCT ID
- NCT00743769
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 79 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Dec 31, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Apr 16, 2017
2008 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Healthcare Discoveries LLC | San Antonio | Texas | 78209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Myocardial Infarction trials
Other public records listing Myocardial Infarction. Sorted by last update posted; newest first. Not a recommendation.
- NCT05925634: Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial Active, not recruiting
- NCT04521699: Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk. Recruiting
- NCT07541014: TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome Recruiting
- NCT06593418: Cardiac Radioablation for VT Not yet recruiting
- NCT03022552: Heart Attack Research Program: Platelet Sub-Study (HARP) Recruiting
- NCT06271577: Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00743769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2017 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00743769 live on ClinicalTrials.gov.